Simplifying sterile access in bioreactor operations. 1990

R Charton

UI MeSH Term Description Entries
D001672 Biocompatible Materials Synthetic or natural materials, other than DRUGS, that are used to replace or repair any body TISSUES or bodily function. Biomaterials,Bioartificial Materials,Hemocompatible Materials,Bioartificial Material,Biocompatible Material,Biomaterial,Hemocompatible Material,Material, Bioartificial,Material, Biocompatible,Material, Hemocompatible
D001709 Biotechnology Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction. Biotechnologies
D013242 Sterilization The destroying of all forms of life, especially microorganisms, by heat, chemical, or other means.

Related Publications

R Charton
October 1948, Wiener klinische Wochenschrift,
R Charton
May 2012, Bioresource technology,
R Charton
December 1984, American journal of hospital pharmacy,
R Charton
January 2024, Echocardiography (Mount Kisco, N.Y.),
R Charton
November 1992, The British journal of general practice : the journal of the Royal College of General Practitioners,
R Charton
October 1996, Laryngo- rhino- otologie,
R Charton
August 1982, Biotechnology and bioengineering,
R Charton
December 1999, The Journal of the Arkansas Medical Society,
R Charton
September 1957, American journal of pharmacy and the sciences supporting public health,
Copied contents to your clipboard!